Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis
- PMID: 38868287
- PMCID: PMC11167500
- DOI: 10.7759/cureus.60186
Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis
Abstract
A myasthenic crisis denotes a severe exacerbation of myasthenia gravis, leading a patient to enter a life-threatening state due to progressing muscle weakness that ultimately results in respiratory failure. A crisis can require intubation, mechanical ventilation, and additional critical care to prevent further decompensation and potentially death. Numerous well-documented precipitating factors exist, such as infections, surgery, stress, and various medications. We present the case of a 43-year-old woman recently diagnosed with myasthenia gravis who has experienced two myasthenic crises since diagnosis without evident triggers such as surgery, changes in medication, or infection. Following an unremarkable initial diagnostic test and continued treatment for the crisis, we sought additional information from the patient's family member at the bedside. We were informed that two weeks prior to both times of crisis with intubation, the patient had dyed her hair blue. The common chemical component in the two different hair dyes used was methylisothiazolinone, which is suspected to have contributed to the exacerbation of the patient's myasthenia gravis. As more evidence for new precipitating factors of myasthenic crises develops, it is crucial for physicians to quickly identify signs and symptoms of a crisis so appropriate intervention can occur in a time-sensitive manner. In addition, myasthenia gravis patients should be made aware to be cautious of precipitating factors of a crisis, including but not limited to new beauty products.
Keywords: autoimmune neuromuscular disease; methylchloroisothiazolinone; methylisothiazolinone; myasthenia gravis (mg); myasthenia gravis exacerbations; myasthenia gravis triggers; myasthenic crisis; refractory myasthenia.
Copyright © 2024, Gomez Rosado et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine.Cureus. 2022 Mar 17;14(3):e23251. doi: 10.7759/cureus.23251. eCollection 2022 Mar. Cureus. 2022. PMID: 35449619 Free PMC article.
-
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature.J Med Case Rep. 2021 Feb 2;15(1):32. doi: 10.1186/s13256-020-02601-8. J Med Case Rep. 2021. PMID: 33526108 Free PMC article. Review.
-
Emergency Department Management of a Myasthenia Gravis Patient with Community-Acquired Pneumonia: Does Initial Antibiotic Choice Lead to Cure or Crisis?J Emerg Med. 2016 Feb;50(2):281-5. doi: 10.1016/j.jemermed.2015.04.019. Epub 2015 Oct 16. J Emerg Med. 2016. PMID: 26472607 Review.
-
Case report: Recovery from refractory myasthenic crisis to minimal symptom expression after add-on treatment with efgartigimod.Front Neurol. 2024 Jan 22;15:1321058. doi: 10.3389/fneur.2024.1321058. eCollection 2024. Front Neurol. 2024. PMID: 38318438 Free PMC article.
-
Successful Control of Myasthenic Crisis After the Introduction of Ravulizumab in Myasthenia Gravis: A Case Report.Cureus. 2024 Nov 20;16(11):e74117. doi: 10.7759/cureus.74117. eCollection 2024 Nov. Cureus. 2024. PMID: 39712723 Free PMC article.
References
-
- Myasthenia gravis. [ Mar; 2024 ]. 2023. https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis https://www.ninds.nih.gov/health-information/disorders/myasthenia-gravis
-
- Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Hehir MK, Silvestri NJ. Neurol Clin. 2018;36:253–260. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials